Parmax Pharma Complete Financial Statements
PARMAX • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Parmax Pharma (PARMAX).
Downloads include all available records across all periods.
For market performance, see the
PARMAX stock price today
.
Profitability Ratios
Net Profit Margin
-7.14%
2025 data
Operating Margin
1.00%
2025 data
Return on Assets
-10.53%
2025 data
Balance Sheet Ratios
Current Ratio
1.25
2025 data
Equity Ratio
-10.53%
2025 data
Asset Turnover
1.47
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-42.9%
Year-over-Year
Net Profit Growth
-150.0%
Year-over-Year
Expense Growth
-32.1%
Year-over-Year
Assets Growth
+26.7%
Year-over-Year
Liabilities Growth
+26.7%
Year-over-Year
Investing Cash Flow Growth
+50.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16 | 28 | 11 | 16 | 18 | 26 | 21 | 12 | 12 | 0 | 0 |
| Expenses | 19 | 28 | 14 | 13 | 16 | 23 | 19 | 11 | 11 | 0 | 0 |
| EBITDA | -3 | 0 | -3 | 2 | 3 | 4 | 2 | 1 | 1 | 0 | 0 |
| Operating Profit Margin % | -27.00% | 1.00% | -31.00% | 15.00% | 14.00% | 13.00% | 8.00% | 9.00% | 9.00% | 0.00% | 0.00% |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | -2 | -6 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -5 | -2 | -6 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Earnings Per Share (₹) | -12.70 | -5.60 | -34.56 | -0.28 | 0.38 | 2.02 | 1.15 | 0.21 | 0.00 | -0.02 | -0.01 |
Related Pages for Parmax Pharma
Additional stock information and data for PARMAX
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Total Assets | 19 | 15 | 18 | 18 | 23 | 21 | 20 | 17 | 8 | 5 |
| Current Assets | 10 | 6 | 8 | 7 | 10 | 9 | 9 | 9 | 4 | 2 |
| Fixed Assets | 8 | 9 | 10 | 10 | 11 | 10 | 5 | 6 | 3 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 10 | 6 | 8 | 8 | 12 | 11 | 11 | 11 | 5 | 3 |
| LIABILITIES | ||||||||||
| Total Liabilities | 19 | 15 | 18 | 18 | 23 | 21 | 20 | 17 | 8 | 5 |
| Current Liabilities | 8 | 6 | 5 | 5 | 6 | 5 | 5 | 2 | 1 | 1 |
| Non-Current Liabilities | ||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||
| Total Equity | -2 | 0 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | -6 | -4 | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 0 | 0 | 1 | 4 | 3 | 1 | 4 | -1 | 0 | 0 |
| Investing Activities | -1 | -2 | -1 | -2 | -3 | -2 | -3 | -4 | 0 | 0 | 0 |
| Financing Activities | 1 | 1 | 0 | -1 | 0 | 0 | 3 | 1 | 1 | 0 | 0 |
| Net Cash Flow | 0 | 0 | -1 | -2 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |